D.J. van Rhenen

2.3k citations

57 papers · 1.8k indexed · h-index 25

Hematology top 0.5%
Biochemistry top 0.5%
Physiology top 5%
Management of Technology and Innovation top 1%
Genetics top 5%

Co-authors: A.J. Gerard Jansen C. Ellen van der Schoot Erik A.M. Beckers M.A.M. Overbeeke Marie‐Louise Essink‐Bot Petra A. Maaskant‐van Wijk B. H. W. Faas Peter C. Ligthart
Topics: Blood groups and transfusion (27 papers)Blood transfusion and management (14 papers)Erythrocyte Function and Pathophysiology (8 papers)
Cited by: Hematology Biochemistry Management of Technology and Innovation
Journals: Blood Cancer Journal of Psychosomatic Research
Partner nations: Netherlands United States Nigeria

In The Last Decade

D.J. van Rhenen

54 papers receiving 1.7k citations

Peers

Countries citing papers authored by D.J. van Rhenen

Since Specialization

Citations

This map shows the geographic impact of D.J. van Rhenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.J. van Rhenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.J. van Rhenen more than expected).

Fields of papers citing papers by D.J. van Rhenen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.J. van Rhenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.J. van Rhenen. The network helps show where D.J. van Rhenen may publish in the future.

Co-authorship network of co-authors of D.J. van Rhenen

This figure shows the co-authorship network connecting the top 25 collaborators of D.J. van Rhenen. A scholar is included among the top collaborators of D.J. van Rhenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.J. van Rhenen. D.J. van Rhenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low‐risk transfusion‐related acute lung injury donor strategies and the impact on the onset of transfusion‐related acute lung injury: a meta‐analysis 2014 ·Transfusion ·Marcella C.A. Müller,Daniëlle Van Stein,Jan M. Binnekade,D.J. van Rhenen,Alexander P. J. Vlaar	45
2	Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction 2010 ·British Journal of Haematology ·(unknown),Wim L.J. van Putten,(unknown),Peter A.W. te Boekhorst,Martin R. Schipperus,Jaap Jan Zwaginga,(unknown),Georgine E. de Greef,Marleen Luten,Peter C. Huijgens,Anneke Brand,D.J. van Rhenen,(unknown)	132
3	Psychometric evaluation of health-related quality of life measures in women after different types of delivery 2007 ·Journal of Psychosomatic Research ·A.J. Gerard Jansen,Marie‐Louise Essink‐Bot,Johannes J. Duvekot,D.J. van Rhenen	63
4	Feasibility of a restrictive red‐cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia 2004 ·Transfusion Medicine ·A.J. Gerard Jansen,Monique A. A. Caljouw,Wim C.J. Hop,D.J. van Rhenen,Martin R. Schipperus	26
5	Functional characteristics of photochemically treated platelets 2004 ·Transfusion ·A.J. Gerard Jansen,Huub H.D.M. van Vliet,(unknown),Erik A.M. Beckers,Frank W.G. Leebeek,Pieter Sonneveld,D.J. van Rhenen	33
6	[Reports of transfusion incidents: experiences from the first year of hemovigilance in the region of the former ZWN (South West Netherlands) blood bank in Rotterdam]. 2003 ·PubMed ·Erik A.M. Beckers,(unknown),Peter A.W. te Boekhorst,(unknown),D.J. van Rhenen	7
7	RHC and RHc genotyping in different ethnic groups 2002 ·Transfusion ·(unknown),C. Ellen van der Schoot,(unknown),(unknown),D.J. van Rhenen,Petra A. Maaskant‐van Wijk	36
8	Partial expression of RHc on the RHD polypeptide 2001 ·Transfusion ·(unknown),Esther A. Beuling,Peter C. Ligthart,D.J. van Rhenen,C. Ellen van der Schoot	14
9	Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD‐specific exons 1998 ·Transfusion ·Petra A. Maaskant‐van Wijk,B. H. W. Faas,(unknown),M.A.M. Overbeeke,A. E. G. Kr. von dem Borne,D.J. van Rhenen,C. Ellen van der Schoot	103
10	The R_o^Har antigenic complex is associated with a limited number of D epitopes and alloanti‐D production: a study of three unrelated persons and their families 1996 ·Transfusion ·Erik A.M. Beckers,Leendert Porcelijn,Peter C. Ligthart,(unknown),(unknown),(unknown),D.J. van Rhenen	15
11	The R₀^Har Rh:33 phenotype results from substitution of exon 5 of the RHCE gene by the corresponding exon of the RHD gene 1996 ·British Journal of Haematology ·Erik A.M. Beckers,B. H. W. Faas,(unknown),M.A.M. Overbeeke,D.J. van Rhenen,C. Ellen van der Schoot	51
12	The genetic basis of a new partial D antigen: D^DBT 1996 ·British Journal of Haematology ·Erik A.M. Beckers,B. H. W. Faas,Suat Şimşek,M.A.M. Overbeeke,D.J. van Rhenen,Mary Wallace,(unknown),C. Ellen van der Schoot	47
13	Rh DNA analysis 1996 ·Transfusion Clinique et Biologique ·Petra A. Maaskant‐van Wijk,B. H. W. Faas,(unknown),Peter C. Ligthart,M.A.M. Overbeeke,A. E. G. Kr. von dem Borne,D.J. van Rhenen,C. Ellen van der Schoot	4
14	Reactions of anti-D monoclonal antibodies with rhesus D variant cells 1996 ·Transfusion Clinique et Biologique ·(unknown),D.J. van Rhenen,Peter C. Ligthart,(unknown),(unknown),(unknown),(unknown),Leendert Porcelijn,A. E. G. Kr. von dem Borne	2
15	Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype 1996 ·Transfusion ·Erik A.M. Beckers,B. H. W. Faas,Peter C. Ligthart,Suat Şimşek,M.A.M. Overbeeke,A. E. G. Kr. v. d. Borne,D.J. van Rhenen,C. Ellen van der Schoot	34
16	Evaluation of a new citrate‐acetate‐NaCl platelet additive solution for the storage of white cell‐reduced platelet concentrates obtained from half‐strength CPD pooled buffy coats 1995 ·Transfusion ·D.J. van Rhenen,(unknown),M. C. Kappers‐Klunne,Jean‐Marc Payrat	46
17	Serological Characteristics of Partial D Antigen Category VI in 8 Unrelated Blood Donors 1994 ·Vox Sanguinis ·D.J. van Rhenen,(unknown),M.A.M. Overbeeke	10
18	Prevention of Primary HLA Class I Allo‐Immunization with Leucocyte‐Poor Blood Components Produced without the Use of Platelet Filters 1992 ·Vox Sanguinis ·(unknown),P.M. van den Berg-Loonen,D.J. van Rhenen	18
19	Relation between leukaemic cell count and degree of maturation in acute myeloid leukaemia 1987 ·European Journal of Cancer and Clinical Oncology ·(unknown),M. M. A. C. Langenhuijsen,Peter C. Huijgens,(unknown),F. C. de Waal,(unknown),D.J. van Rhenen,(unknown)	4
20	Changes in the surface marker pattern related to maturation in adult acute myeloid leukaemia 1983 ·Leukemia Research ·D.J. van Rhenen,(unknown),Mars B. van ’t Veer,C. P. Engelfriet,(unknown),M. M. A. C. Langenhuijsen	8

About D.J. van Rhenen

D.J. van Rhenen is a scholar working on Hematology, Biochemistry and Management of Technology and Innovation, having authored 57 papers that have together received 1.8k indexed citations. Recurring topics across this work include Blood groups and transfusion (27 papers), Blood transfusion and management (14 papers) and Erythrocyte Function and Pathophysiology (8 papers). The work is most often cited by research in Hematology (1.1k citations), Biochemistry (572 citations) and Management of Technology and Innovation (308 citations). D.J. van Rhenen has collaborated with scholars based in Netherlands, United States and Nigeria. Frequent co-authors include A.J. Gerard Jansen, C. Ellen van der Schoot, Erik A.M. Beckers, M.A.M. Overbeeke, Marie‐Louise Essink‐Bot, Petra A. Maaskant‐van Wijk, B. H. W. Faas, Peter C. Ligthart, Wim C.J. Hop and Martin R. Schipperus. Their work appears in journals such as Blood, Cancer and Journal of Psychosomatic Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact